Literature DB >> 15485835

Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5.

Tai-Guang Jin1, Alexei Kurakin, Nordine Benhaga, Karon Abe, Mehrdad Mohseni, Ferry Sandra, Keli Song, Brian K Kay, Roya Khosravi-Far.   

Abstract

Here we show a novel mechanism by which FLICE-like inhibitory protein (c-FLIP) regulates apoptosis induced by tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and one of its receptors, DR5. c-FLIP is a critical regulator of the TNF family of cytokine receptor signaling. c-FLIP has been postulated to prevent formation of the competent death-inducing signaling complex (DISC) in a ligand-dependent manner, through its interaction with FADD and/or caspase-8. In order to identify regulators of TRAIL function, we used the intracellular death domain (DD) of DR5 as a target to screen a phage-displayed combinatorial peptide library. The DD of DR5 selected from the library a peptide that showed sequence similarity to a stretch of amino acids in the C terminus of c-FLIP(L). The phage-displayed peptide selectively interacted with the DD of DR5 in in vitro binding assays. Similarly, full-length c-FLIP (c-FLIP(L)) and the C-terminal p12 domain of c-FLIP interacted with DR5 both in in vitro pull-down assays and in mammalian cells. This interaction was independent of TRAIL. To the contrary, TRAIL treatment released c-FLIP(L) from DR5, permitting the recruitment of FADD to the active DR5 signaling complex. By employing FADD-deficient Jurkat cells, we demonstrate that DR5 and c-FLIP(L) interact in a FADD-independent manner. Moreover, we show that a cellular membrane permeable version of the peptide corresponding to the DR5 binding domain of c-FLIP induces apoptosis in mammalian cells. Taken together, these findings indicate that c-FLIP interacts with the DD of DR5, thus preventing death (L)signaling by DR5 prior to the formation of an active DISC. Because TRAIL and DR5 are ubiquitously expressed, the interaction of c-FLIP(L) and DR5 indicates a mechanism by which tumor selective apoptosis can be achieved through protecting normal cells from undergoing death receptor-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15485835      PMCID: PMC2981793          DOI: 10.1074/jbc.M401056200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  72 in total

Review 1.  Death and survival signals determine active/inactive conformations of pro-apoptotic BAX, BAD, and BID molecules.

Authors:  S J Korsmeyer; A Gross; H Harada; J Zha; K Wang; X M Yin; M Wei; S Zinkel
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1999

Review 2.  Insights into programmed cell death through structural biology.

Authors:  S W Fesik
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

3.  Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development.

Authors:  W C Yeh; A Itie; A J Elia; M Ng; H B Shu; A Wakeham; C Mirtsos; N Suzuki; M Bonnard; D V Goeddel; T W Mak
Journal:  Immunity       Date:  2000-06       Impact factor: 31.745

Review 4.  FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis.

Authors:  A Krueger; S Baumann; P H Krammer; S Kirchhoff
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

Review 5.  The machinery of programmed cell death.

Authors:  K C Zimmermann; C Bonzon; D R Green
Journal:  Pharmacol Ther       Date:  2001-10       Impact factor: 12.310

Review 6.  Convergent evolution with combinatorial peptides.

Authors:  B K Kay; J Kasanov; S Knight; A Kurakin
Journal:  FEBS Lett       Date:  2000-08-25       Impact factor: 4.124

7.  The short splice form of Casper/c-FLIP is a major cellular inhibitor of TRAIL-induced apoptosis.

Authors:  Lianghua Bin; Xiaoyan Li; Liang-Guo Xu; Hong-Bing Shu
Journal:  FEBS Lett       Date:  2002-01-02       Impact factor: 4.124

Review 8.  The complexity of TNF-related apoptosis-inducing ligand.

Authors:  K Abe; A Kurakin; M Mohseni-Maybodi; B Kay; R Khosravi-Far
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

9.  Identification of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approach.

Authors:  T F Burns; W S El-Deiry
Journal:  J Biol Chem       Date:  2001-08-02       Impact factor: 5.157

10.  Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

Authors:  F C Kischkel; D A Lawrence; A Chuntharapai; P Schow; K J Kim; A Ashkenazi
Journal:  Immunity       Date:  2000-06       Impact factor: 31.745

View more
  13 in total

1.  B lymphocytes are resistant to death receptor 5-induced apoptosis.

Authors:  Roslyn N Crowder; Hong Zhao; W Winn Chatham; Tong Zhou; Robert H Carter
Journal:  Clin Immunol       Date:  2011-01-28       Impact factor: 3.969

2.  Transduction of tumor necrosis factor-related apoptosis-inducing ligand into hematopoietic cells leads to inhibition of syngeneic tumor growth in vivo.

Authors:  Keli Song; Nordine Benhaga; Robin L Anderson; Roya Khosravi-Far
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

3.  Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2.

Authors:  Delphine Mérino; Najoua Lalaoui; Alexandre Morizot; Pascal Schneider; Eric Solary; Olivier Micheau
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

Review 4.  Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities.

Authors:  Jessica Plati; Octavian Bucur; Roya Khosravi-Far
Journal:  J Cell Biochem       Date:  2008-07-01       Impact factor: 4.429

Review 5.  Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy.

Authors:  Ahmad R Safa; Travis W Day; Ching-Huang Wu
Journal:  Curr Cancer Drug Targets       Date:  2008-02       Impact factor: 3.428

Review 6.  c-FLIP, a master anti-apoptotic regulator.

Authors:  A R Safa
Journal:  Exp Oncol       Date:  2012-10

7.  TRAIL recombinant adenovirus triggers robust apoptosis in multidrug-resistant HL-60/Vinc cells preferentially through death receptor DR5.

Authors:  Ching-Huang Wu; Ching-Hai Kao; Ahmad R Safa
Journal:  Hum Gene Ther       Date:  2008-07       Impact factor: 5.695

8.  Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induced mitochondrial pathway to apoptosis and caspase activation is potentiated by phospholipid scramblase-3.

Authors:  Kenneth Ndebele; Philimon Gona; Tai-Guang Jin; Nordine Benhaga; Anas Chalah; Mauro Degli-Esposti; Roya Khosravi-Far
Journal:  Apoptosis       Date:  2008-07       Impact factor: 4.677

9.  c-FLIP knockdown induces ligand-independent DR5-, FADD-, caspase-8-, and caspase-9-dependent apoptosis in breast cancer cells.

Authors:  Travis W Day; Su Huang; Ahmad R Safa
Journal:  Biochem Pharmacol       Date:  2008-09-17       Impact factor: 5.858

10.  Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy.

Authors:  Ahmad R Safa; Karen E Pollok
Journal:  Cancers (Basel)       Date:  2011-06       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.